Gerber, Philipp A.

The Role of Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in Diabetes Mellitus

Gerber, P. A., & Rutter, G. A. (2017) · Antioxidants & Redox Signaling

Pancreatic function and diabetesEndoplasmic Reticulum Stress and Disease

Cited by 654

Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial

Aeberli, I., Gerber, P. A., Hochuli, M., Kohler, S., Haile, S. R., Gouni-Berthold, I., Berthold, H. K., Spinas, G. A., & Berneis, K. (2011) · The American Journal of Clinical Nutrition

Diet, Metabolism, and DiseaseDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 372

Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial

Geidl-Flueck, B., Hochuli, M., Németh, Á., Eberl, A., Derron, N., Köfeler, H. C., Tappy, L., Berneis, K., Spinas, G. A., & Gerber, P. A. (2021) · Journal of Hepatology

Diet, Metabolism, and DiseaseLiver Disease Diagnosis and Treatment

Cited by 238

Exercise Prevents Fructose-Induced Hypertriglyceridemia in Healthy Young Subjects

Egli, L., Lecoultre, V., Theytaz, F., Campos, V., Hodson, L., Schneiter, P., Mittendorfer, B., Patterson, B. W., Fielding, B. A., Gerber, P. A., et al. (2013) · Diabetes

Diet, Metabolism, and DiseaseDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 102

Glycemic Control in Simultaneous Islet-Kidney Versus Pancreas-Kidney Transplantation in Type 1 Diabetes: A Prospective 13-Year Follow-up

Lehmann, R., Graziano, J., Brockmann, J., Pfammatter, T., Kron, P., de Rougemont, O., Mueller, T., Zuellig, R. A., Spinas, G. A., & Gerber, P. A. (2015) · Diabetes Care

Pancreatic function and diabetesRenal Transplantation Outcomes and Treatments

Cited by 94

Insights into the Hexose Liver Metabolism—Glucose versus Fructose

Geidl-Flueck, B., & Gerber, P. (2017) · Nutrients

Diet, Metabolism, and DiseaseMetabolism, Diabetes, and Cancer

Cited by 85

GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit–harm modelling study

Moll, H., Frey, E., Gerber, P., Geidl, B., Kaufmann, M., Braun, J., Beuschlein, F., Puhan, M. A., & Yebyo, H. G. (2024) · eClinicalMedicine

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 73

Weight loss and treatment patterns in a real‐world population of adults receiving liraglutide 3.0 mg for weight management in routine clinical practice in Switzerland ( ADDRESS study)

Schultes, B., Timper, K., Cavadini, G., Rüh, J., & Gerber, P. A. (2024) · Diabetes, Obesity and Metabolism

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 13